Atazanavir and Cardiovascular Risk Among Human Immunodeficiency Virus-Infected Patients: A Systematic Review

INTRODUCTION: Patients with human immunodeficiency virus (HIV) infection have an increased risk of cardiovascular disease (CVD). While viral suppression with antiretroviral therapy decreases CVD risk overall, several studies have suggested that certain antiretrovirals, particularly certain protease...

Descripción completa

Detalles Bibliográficos
Autores principales: Chow, Dominic, Shikuma, Cecilia, Ritchings, Corey, Guo, Muxing, Rosenblatt, Lisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5125135/
https://www.ncbi.nlm.nih.gov/pubmed/27677263
http://dx.doi.org/10.1007/s40121-016-0132-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5125135/
https://www.ncbi.nlm.nih.gov/pubmed/27677263
http://dx.doi.org/10.1007/s40121-016-0132-z

Ejemplares similares